As the table further demonstrates, the non-cancer patient populations in the U.S. (controls for the Austrian study) [1] and Italy [14] demonstrated a relative low prevalence of low FMR1 alleles in the 20.5–23.1% range, while Israeli controls were reported to demonstrate as much a 31.5% low FMR1 alleles. The gene discussed is FMR1; the disease is cancer.